胆碱酯酶拮抗剂六甲撑 - 双（N - 甲基氨基甲酰基 - 1 - 甲基 - 3 - 氧代吡啶溴化物）；（BC 51）的药理及临床作用 - Suppr

Suppr

超能文献

[Pharmacological and clinical effects of cholinesterase antagonist hexamethylene-bis(N-methylcarbaminoyl-1-methyl-3-oxypyridiniumbromide); (BC 51)].

作者信息

HERZFELD E, KRAUPP O, PATEISKY K, STUMPF C

出版信息

Wien Klin Wochenschr. 1957 Apr 5;69(14):245-8.

PMID:13443301

Abstract

摘要

相似文献

[Pharmacological and clinical effects of cholinesterase antagonist hexamethylene-bis(N-methylcarbaminoyl-1-methyl-3-oxypyridiniumbromide); (BC 51)].胆碱酯酶拮抗剂六甲撑 - 双（N - 甲基氨基甲酰基 - 1 - 甲基 - 3 - 氧代吡啶溴化物）；（BC 51）的药理及临床作用

Wien Klin Wochenschr. 1957 Apr 5;69(14):245-8.

[Effect of polymethylene-bis-(N-methyl-carbamic acid-m-trimethylammonium-phenol) BC 40, BC 47, BC 48 on cholinesterase activity and muscle activity in myasthenia gravis pseudoparalytica].[聚亚甲基双（N-甲基氨基甲酸间三甲铵基苯酚）BC 40、BC 47、BC 48对假麻痹性重症肌无力胆碱酯酶活性及肌肉活动的影响]

Wien Klin Wochenschr. 1957 Jan 4;69(1):2-7.

[Studies on cholinesterase inhibiting effects of polymethylene-bis-(N-methyl-carbamic acid-m-trimethylammoniumphenols)].[聚亚甲基双（N-甲基氨基甲酸间三甲基铵基苯酚）的胆碱酯酶抑制作用研究]

Arch Int Pharmacodyn Ther. 1956 Jul 1;107(1):33-44.

[Variations in permeability induced by decamethylene-bis-(N-methyl-carbamic acid-m-trimethylammoniumphenol) (BC 48)].[由十亚甲基双（N-甲基氨基甲酰基间三甲铵基苯酚）（BC 48）诱导的通透性变化]

Arch Int Pharmacodyn Ther. 1956 Dec 1;108(3-4):481-7.

[The effect of new cholinesterase retarding substance on sympathicotonic circulation disorder, with special reference to angina pectoris].[新型胆碱酯酶抑制物质对交感神经亢进性循环障碍的影响，特别是对心绞痛的影响]

Z Kreislaufforsch. 1956 Nov;45(21-22):863-74.

[Decamethylene-bis-neostigmine bromide (BC-48) in therapy of ocular hypertension].[十亚甲基双新斯的明溴化物（BC-48）治疗高眼压症]

Bull Mem Soc Fr Ophtalmol. 1957;70:518-36; discussion 537-9.

[Repression of cholinergic depot substances in reactive thyroid gland follicular hyperplasia in female rats].[雌性大鼠反应性甲状腺滤泡增生中胆碱能贮存物质的抑制作用]

Z Geburtshilfe Gynakol. 1956;147(2):226-31.

[Cholinesterase inhibition in liver diseases by additional loading with BC 51 (ubretid)].通过额外加载BC 51（乌布立特）对肝脏疾病中胆碱酯酶的抑制作用

Wien Klin Wochenschr. 1958 Oct 17;70(42):808-10.

[Use of decamethylene-bis-(N-methylcarbaminoyl-m-trimethylammoniumphenol) (BC 48) in therapy of glaucoma].[癸亚甲基-双-(N-甲基氨基甲酰基间三甲铵基苯酚)(BC 48)在青光眼治疗中的应用]

Albrecht Von Graefes Arch Ophthalmol. 1956;157(5):473-94.

Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.1-[双(4-氟苯基)-甲基]哌嗪衍生物作为阿尔茨海默病中枢胆碱能神经传递刺激剂对乙酰胆碱酯酶抑制的合成及疗效

Bioorg Med Chem Lett. 2006 Aug 1;16(15):3932-6. doi: 10.1016/j.bmcl.2006.05.030. Epub 2006 Jun 2.

引用本文的文献

[Ureteral atony caused by surgery in animal experimentation and its influence by drugs].[动物实验中手术所致输尿管无张力及其受药物的影响]

Arch Gynakol. 1962;197:402-6. doi: 10.1007/BF00668696.

[On the influence of prolonged cholinesterase inhibition on the results of various studies of portal and hepatic blood circulation].[长期胆碱酯酶抑制对门静脉和肝血液循环各项研究结果的影响]

Klin Wochenschr. 1961 Jan 15;39:87-92. doi: 10.1007/BF01884871.

Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes.季铵吡啶肟对致死性有机磷酸酯中毒的防护作用。

Br J Pharmacol Chemother. 1959 Jun;14(2):192-201. doi: 10.1111/j.1476-5381.1959.tb01383.x.

Therapy of myasthenia gravis.重症肌无力的治疗

Bull N Y Acad Med. 1959 Apr;35(4):231-40.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验